Institutional investors purchased a net $1.4 million shares of RGEN during the quarter ended September 2017, and now own 86.89% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MACKENZIE FINANCIAL CORP. Bought 802.8 Thousand shares of Repligen Corp
WILLIAM BLAIR INVESTMENT MANAGEM... Bought 742.6 Thousand shares of Repligen Corp
SSGA FUNDS MANAGEMENT, INC. Bought 549.2 Thousand shares of Repligen Corp